OrthoPediatrics Corp. (NASDAQ:KIDS) Short Interest Up 10.9% in December

OrthoPediatrics Corp. (NASDAQ:KIDS) saw a large increase in short interest in the month of December. As of December 31st, there was short interest totalling 912,100 shares, an increase of 10.9% from the December 15th total of 822,400 shares. Approximately 5.6% of the shares of the stock are sold short. Based on an average trading volume of 211,000 shares, the short-interest ratio is currently 4.3 days.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on KIDS shares. Truist Financial lowered their price target on OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating on the stock in a report on Wednesday, December 18th. Needham & Company LLC reiterated a “buy” rating and set a $42.00 target price on shares of OrthoPediatrics in a research report on Tuesday, January 14th.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the business. Divisadero Street Capital Management LP purchased a new stake in OrthoPediatrics in the 2nd quarter valued at approximately $514,000. Wellington Management Group LLP lifted its position in shares of OrthoPediatrics by 16.2% in the third quarter. Wellington Management Group LLP now owns 883,221 shares of the company’s stock valued at $23,944,000 after acquiring an additional 122,846 shares in the last quarter. Harbor Capital Advisors Inc. lifted its position in shares of OrthoPediatrics by 268.1% in the third quarter. Harbor Capital Advisors Inc. now owns 246,860 shares of the company’s stock valued at $6,692,000 after acquiring an additional 179,803 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of OrthoPediatrics by 2.1% during the third quarter. Geode Capital Management LLC now owns 391,492 shares of the company’s stock valued at $10,615,000 after acquiring an additional 7,972 shares during the last quarter. Finally, Barclays PLC increased its position in OrthoPediatrics by 319.3% during the 3rd quarter. Barclays PLC now owns 25,298 shares of the company’s stock worth $686,000 after purchasing an additional 19,264 shares in the last quarter. 69.05% of the stock is owned by hedge funds and other institutional investors.

OrthoPediatrics Price Performance

NASDAQ:KIDS opened at $27.16 on Friday. The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.17. The firm has a 50-day moving average price of $23.98 and a two-hundred day moving average price of $27.34. OrthoPediatrics has a twelve month low of $21.02 and a twelve month high of $35.99.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.